 N EnglJ Med 334:759±762
De Visser MCH, Rosendaal FR, Bertina RM (1999) A reduced
sensitivity for activated protein C in the absence of factorV Leiden increases the risk of venous thrombosis. Blood 93:1271±1276
Doggen CJM, Cats VM, Bertina RM, Reitsma PH, Vanden-
broucke JP, Rosendaal FR (1998) A genetic propensity tohigh factor VII is not associated with risk of myocardialinfarction in men. Thromb Haemost 80:281±285
Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL,
Leach RJ, O'Connell P, Stern MP (1999 a) Linkage of type
2 diabetes mellitus and of age at onset to a genetic locationon chromosome 10q in Mexican Americans. Am J HumGenet 64:1127±1140
Duggirala R, Mitchell BD, Blangero J, Stern MP (1999 b) Ge-
netic determinants of variation in gallbladder disease in theMexican-American population. Genet Epidemiol 16:191±204
Duggirala R, Williams JT, Williams-Blangero S, Blangero J
(1997) A variance component approach to dichotomoustrait linkage analysis using a threshold model. Genet Epi-demiol 14:987±992
Ernst E, Resch KL (1993) Fibrinogen as a cardiovascular risk
factor: a meta-analysis and review of the literature. AnnIntern Med 118:956±963
Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless
LE (1997) Prospective study of hemostatic factors and in-cidence of coronary heart disease: the atherosclerosis risk incommunities (ARIC) study. Circulation 96:1102±1108Hamsten A, DeFaire U, Walldius G, Dahlen G, Szamosi A,
Landou C, Blomback M, Wiman B (1987) Plasminogen ac-tivator inhibitor in plasma: risk factor for recurrent myo-cardial infarction. Lancet 2:3±9
Hasstedt SJ, Bovill EG, Callas PW, Long GL (1998) An un-
known genetic defect increases venous thrombosis risk,through interaction with protein C de®ciency. Am J HumGenet 63:569±576
Hopper JL, Mathews JD (1982) Extensions to multivariate
normal models for pedigree analysis. Ann Hum Genet 46:373±383
Hyland K, Bottiglieri T (1992) Measurement of total plasma
and cerebrospinal ¯uid homocysteine by ¯uorescence fol-lowing high-performance liquid chromatography and pre-column derivatization with o-phthaldialdehyde. J Chro-matogr 579:55±62
Iacoviello L, Di Castelnuovo A, de Knijff P, D'Orazio A, Amore
C, Arboretti R, Kluft C, Benedetta Donati M (1998) Poly-morphisms in the coagulation factor VII gene and the riskof myocardial infarction. N Engl J Med 338:79±85
Kendall MG, Stuart A (1972) Advanced theory of statistics.
Hafner, New York
Kohler HP, Carter AM, Strickland MH, Grant PJ (1998) Levels
of activated FXII in survivors of myocardial infarction: as-sociation with circulating risk factors and extent of coronaryartery disease. Thromb Haemost 79:14±18
Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal
FR (1995) Role of clotting factor VIII in effect of von Wil-lebrand factor on occurrence of deep-vein thrombosis. Lan-cet 345:152±155
Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet
E, Vandenbroucke JP (1994) Factor VII and ®brinogen levelsas risk factors for venous thrombosis. Thromb Haemost 71:719±722
Lane DA, Mannucci PM, Bauer KA, Bertina RM, Boehkov
NP, Boulyjenkov V, Chandy M, Dahlback B, Ginter EK,Miletich JP, Rosendaal FR, Seligsohn U (1996) Inheritedthrombophilia: part 1. Thromb Haemost 76:651±662
MacCallum PK, Meade TW, Cooper JA, Stirling Y, Howarth
DJ, Ruddock V, Miller GJ (1995) Clotting factor VIII andrisk of deep-vein thrombosis. Lancet 345:804
Mahaney MC, Czerwinski SA, Adachi T, Wilcken DEL, Wang
XL (2000) Plasma levels of extracellular superoxide dis-mutase in an Australian population: genetic contribution tonormal variation and correlations with plasma nitric oxideand apolipoprotein A±I levels. Arterioscler Thromb VascBiol 20:683±688
Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti
RR, North WR, Haines AP, Stirling Y, Imeson JD, Thomp-son SG (1986) Hemostatic function and ischemic heart dis-ease: principal results of the Northwick Park study. Lancet2:533±537
Meijers JCM, Tekelenburg WLH, Bouma BN, Bertina RM,
Rosendaal FR (2000) High levels of coagulation factor XIas a risk factor for venous thrombosis. N Engl J Med 342:696±701
Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T (1992)
A prospective study of the incidence of deep-vein thrombosisSouto et al.: Genetics of Thrombosis: The GAIT Study 1459
within a de®ned urban population. J Intern Med 232:155±
160
Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad
M, Vollset SE (1997) Plasma homocysteine levels and mor-tality in patients with coronary artery disease. N Engl J Med337:230±236
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A
common genetic variation in the 3
0-untranslated region of
the prothrombin gene is associated with elevated plasmaprothrombin levels and an increase in venous thrombosis.